We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSGS icon
1676
Madison Square Garden
MSGS
$9.47B
$1.94M ﹤0.01%
10,142
+2,068
+26% +$402K
PBH icon
1677
Prestige Consumer Healthcare
PBH
$2.54B
$1.93M ﹤0.01%
62,500
-1,001
-2% -$36.5K
LFC
1678
DELISTED
China Life Insurance Company Ltd.
LFC
$1.93M ﹤0.01%
184,026
+12,080
+7% +$128K
CLPR
1679
Clipper Realty
CLPR
$47M
$1.93M ﹤0.01%
147,352
-4,842
-3% -$63.5K
ELLI
1680
DELISTED
Ellie Mae Inc
ELLI
$1.93M ﹤0.01%
30,651
-2,125
-6% -$151K
SPTL icon
1681
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.7B
$1.93M ﹤0.01%
+54,935
New +$1.83M
PID icon
1682
Invesco International Dividend Achievers ETF
PID
$913M
$1.92M ﹤0.01%
135,994
-27,365
-17% -$409K
SHPG
1683
DELISTED
Shire pic
SHPG
$1.92M ﹤0.01%
11,001
-43,058
-80% -$7.53M
WLL
1684
DELISTED
Whiting Petroleum Corporation
WLL
$1.91M ﹤0.01%
1,122
+15
+1% +$38.5K
PAG icon
1685
Penske Automotive Group
PAG
$14.2B
$1.9M ﹤0.01%
47,032
+32,000
+213% +$1.38M
TRTN
1686
DELISTED
Triton International Limited
TRTN
$1.89M ﹤0.01%
60,815
+3,731
+7% +$120K
STMP
1687
DELISTED
Stamps.com, Inc.
STMP
$1.89M ﹤0.01%
12,143
+10,235
+536% +$1.82M
GRX
1688
Gabelli Healthcare & Wellness Trust
GRX
$147M
$1.89M ﹤0.01%
203,770
-58,875
-22% -$605K
SNN icon
1689
Smith & Nephew
SNN
$12.6B
$1.89M ﹤0.01%
50,418
+2,219
+5% +$79.8K
BHC icon
1690
Bausch Health
BHC
$2.33B
$1.88M ﹤0.01%
101,840
-46,423
-31% -$1.1M
SKYW icon
1691
Skywest
SKYW
$4.19B
$1.88M ﹤0.01%
42,327
+9,889
+30% +$511K
IHE icon
1692
iShares US Pharmaceuticals ETF
IHE
$1.65B
$1.88M ﹤0.01%
39,987
-16,464
-29% -$844K
LGND icon
1693
Ligand Pharmaceuticals
LGND
$5.76B
$1.88M ﹤0.01%
22,155
-5,468
-20% -$583K
TSE
1694
DELISTED
Trinseo
TSE
$1.87M ﹤0.01%
40,917
+34,683
+556% +$1.89M
ACHC icon
1695
Acadia Healthcare
ACHC
$2.9B
$1.87M ﹤0.01%
72,684
-14,163
-16% -$490K
LGIH icon
1696
LGI Homes
LGIH
$1.34B
$1.87M ﹤0.01%
41,317
-2,209
-5% -$93.3K
JCAP
1697
DELISTED
Jernigan Capital, Inc.
JCAP
$1.86M ﹤0.01%
94,113
-9,505
-9% -$193K
IOO icon
1698
iShares Global 100 ETF
IOO
$9.41B
$1.86M ﹤0.01%
43,974
+19,239
+78% +$877K
PJT icon
1699
PJT Partners
PJT
$4.48B
$1.86M ﹤0.01%
48,084
-2,288
-5% -$103K
MTDR icon
1700
Matador Resources
MTDR
$6.51B
$1.86M ﹤0.01%
119,855
+60,152
+101% +$1.51M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.